RareGenetics.be Information

RareGenetics is a specialist consultancy dedicated to the commercialization of orphan drugs and therapies for rare diseases. With over 23 years of hands-on experience in rare disease commercial sales, marketing, pricing, and market access, RareGenetics.be guides both startups and established pharmaceutical companies that are new to the rare disease space, and this from early strategic choices through to successful market entry and sustainable long-term growth. Based in Belgium and operating across Europe, RareGenetics.be delivers the kind of senior commercial leadership that most small and mid-size orphan drug companies cannot build in-house, and that generalist consultancies simply cannot replicate. The firm was founded on a clear conviction: rare disease assets don’t fail because of the science. They fail because companies apply the wrong commercial model. Standard primary care or specialty pharma playbooks break down completely in ultra-low prevalence settings, where every patient counts, every physician relationship matters, and every pricing negotiation can define the long-term viability of a therapy. 1. Rare Disease Commercial Marketing & Launch Excellence 2. Distribution Pathway Optimisation 3. Pricing Negotiation & Payer Strategy 4. Pre-Launch Patient Journey Analysis 5. HCP Education & KOL Engagement 6. Market Research & Landscape Analysis 7. Reimbursement, Market Access & Managed Access (MNPs, Compassionate Use, Patient Support Services) 8. European & International Expansion 9. Fractional & Interim Commercial Leadership